Fig. 2

Aberrant LINC01419 expression affects LUAD stem cell properties. A qRT-PCR and western blot were used to detect the expression level of LINC01419 and CD44, respectively; B qRT-PCR was used to detect the expression level of LINC01419 in oe-LINC01419 cells and sh-LINC01419 cells; C CCK-8 was used to detect the cell proliferation viability of oe-LINC01419 cells and sh-LINC01419 cells; D Tumor sphere-forming assay was used to detect the sphere-forming ability of LUAD cells; E Western blot was used to detect the expression levels of LUAD-CSC surface markers CD44, CD133 and ALDH-1 in the cells of each treatment group; *P < 0.05 indicates significant differences